BioSpace News Archive

Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today announced the election of the eleven directors nominated at its 2020 annual meeting of shareholders held on April 28, 2020.

Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, today released its fourth quarter and full year 2019 financial results.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”) is pleased to announce new data are scheduled to be presented in two poster presentations during the American Society of Clinical Oncology’s (ASCO) Annual Meeting, a leading global scientific meeting for oncology professionals, taking place from 29 May – 31 May 2020

A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.

ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered development of SARS-CoV-2 vaccine candidates based on its virus-like particle (VLP) based platform technologies METAVAX® and SplitCore.

BioAge’s proprietary platform of human aging data demonstrates that the Hypoxia-inducible factor (HIF) pathway is linked to healthspan and lifespan

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 31 March 2020 . First-Quarter Reported Results (1)

IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry, has joined the ACCORD-2 collaboration, which will fast-track development of new treatments for COVID-19. IQVIA will provide a single research platform across the United Kingdom to facilitate multiple clinical trials regardless of sponsor.

United Spinal Association is launching its Tech Access Initiative to assist technology companies in designing inclusive products and services that are accessible to people with spinal cord injuries and disorders (SCI/D).